Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose

Recruiting N/A Interventional Study
Type 1 Diabetes Mellitus
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 24
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
Jane Yardley · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
People living with type 1 diabetes (PwT1D) are recommended to administer insulin 10-15 minutes before meal consumption (pre-bolus), to account for the delay in the glucose lowering action associated with subcutaneously administered insulin. Due to the demands of day-to-day life, pre-bolusing is not always possible or may be forgotten. With continuous glucose monitors (CGMs), PwT1D may be alerted t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults aged 18-24 years * Type 1 diabetes diagnostic for at least two years * Estimated glycated hemoglobin or glucose management indicator obtained from the past 30 days of CGM data of \< 9.9% * Use a Dexcom G7 CGM in routine care Exclusion Criteria: * Changes in insulin ma…
Contacts

Corinne Suppère, MSc

514-987-5597

corinne.suppere@ircm.qc.ca

CONTACT

Jane Yardley, PhD

514-987-5568

jane.yardley@ircm.qc.ca

CONTACT